What is the impact of circulating histones in COVID-19: a systematic review.
COVID-19
NETosis
NETs
SARS-CoV-2
citrullinated histone
heparins and heparinoids
histone
systematic review
thrombo-inflammation
Journal
Clinical chemistry and laboratory medicine
ISSN: 1437-4331
Titre abrégé: Clin Chem Lab Med
Pays: Germany
ID NLM: 9806306
Informations de publication
Date de publication:
27 09 2022
27 09 2022
Historique:
received:
13
06
2022
accepted:
08
07
2022
pubmed:
20
7
2022
medline:
31
8
2022
entrez:
19
7
2022
Statut:
epublish
Résumé
The infectious respiratory condition COVID-19 manifests a clinical course ranging from mild/moderate up-to critical systemic dysfunction and death linked to thromboinflammation. During COVID-19 infection, neutrophil extracellular traps participating in cytokine storm and coagulation dysfunction have emerged as diagnostic/prognostic markers. The characterization of NET identified that mainly histones, have the potential to initiate and propagate inflammatory storm and thrombosis, leading to increased disease severity and decreased patient survival. Baseline assessment and serial monitoring of blood histone concentration may be conceivably useful in COVID-19. We performed a literature review to explore the association among increased circulating levels of histones, disease severity/mortality in COVID-19 patients, and comparison of histone values between COVID-19 and non-COVID-19 patients. We carried out an electronic search in Medline and Scopus, using the keywords "COVID-19" OR "SARS-CoV-2" AND "histone" OR "citrullinated histones" OR "hyperhistonemia", between 2019 and present time (i.e., June 07th, 2022), which allowed to select 17 studies, totaling 1,846 subjects. We found that substantially elevated histone values were consistently present in all COVID-19 patients who developed unfavorable clinical outcomes. These findings suggest that blood histone monitoring upon admission and throughout hospitalization may be useful for early identification of higher risk of unfavorable COVID-19 progression. Therapeutic decisions in patients with SARS-CoV-2 based on the use of histone cut-off values may be driven by drugs engaging histones, finally leading to the limitation of cytotoxic, inflammatory, and thrombotic effects of circulating histones in viral sepsis.
Identifiants
pubmed: 35852070
pii: cclm-2022-0574
doi: 10.1515/cclm-2022-0574
doi:
Substances chimiques
Histones
0
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1506-1517Informations de copyright
© 2022 Walter de Gruyter GmbH, Berlin/Boston.
Références
Lotfi, M, Hamblin, MR, Rezaei, N. COVID-19: transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta 2020;508:254–66, https://doi.org/10.1016/j.cca.2020.05.044.
Kgatle, MM, Lawal, IO, Mashabela, G, Boshomane, TMG, Koatale, PC, Mahasha, PW, et al.. COVID-19 is a multi-organ aggressor: epigenetic and clinical marks. Front Immunol 2021;12:752380, https://doi.org/10.3389/fimmu.2021.752380.
Conceição-Silva, F, Reis, CSM, De Luca, PM, Leite-Silva, J, Santiago, MA, Morrot, A, et al.. The immune system throws its traps: cells and their extracellular traps in disease and protection. Cells 2021;10:1891. https://doi.org/10.3390/cells10081891.
Block, H, Rossaint, J, Zarbock, A. The fatal circle of NETs and NET-associated DAMPs contributing to organ dysfunction. Cells 2022;11:1919. https://doi.org/10.3390/cells11121919.
Chen, R, Kang, R, Fan, XG, Tang, D. Release and activity of histone in diseases. Cell Death Dis 2014;5:e1370, https://doi.org/10.1038/cddis.2014.337.
Moiana, M, Aranda, F, de Larranaga, G. A focus on the roles of histones in health and diseases. Clin Biochem 2021;94:12–9, https://doi.org/10.1016/j.clinbiochem.2021.04.019.
Ligi, D, Maniscalco, R, Plebani, M, Lippi, G, Mannello, F. Do circulating histones represent the missing link among COVID-19 infection and multiorgan injuries, microvascular coagulopathy and systemic hyperinflammation? J Clin Med 2022;11:1800, https://doi.org/10.3390/jcm11071800.
Xu, J, Zhang, X, Pelayo, R, Monestier, M, Ammollo, CT, Semeraro, F, et al.. Extracellular histones are major mediators of death in sepsis. Nat Med 2009;15:1318–21, https://doi.org/10.1038/nm.2053.
Ekaney, ML, Otto, GP, Sossdorf, M, Sponholz, C, Boehringer, M, Loesche, W, et al.. Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation. Crit Care 2014;18:543, https://doi.org/10.1186/s13054-014-0543-8.
Li, Y, Wan, D, Luo, X, Song, T, Wang, Y, Yu, Q, et al.. Circulating histones in sepsis: potential outcome predictors and therapeutic targets. Front Immunol 2021;12:650184, https://doi.org/10.3389/fimmu.2021.650184.
Silk, E, Zhao, H, Weng, H, Ma, D. The role of extracellular histone in organ injury. Cell Death Dis 2017;8:e2812, https://doi.org/10.1038/cddis.2017.52.
Pourbagheri-Sigaroodi, A, Bashash, D, Fateh, F, Abolghasemi, H. Laboratory findings in COVID-19 diagnosis and prognosis. Clin Chim Acta 2020;510:475–82, https://doi.org/10.1016/j.cca.2020.08.019.
Henry, BM, de Oliveira, MHS, Benoit, S, Plebani, M, Lippi, G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med 2020;58:1021–8, https://doi.org/10.1515/cclm-2020-0369.
Ondracek, AS, Lang, IM. Neutrophil extracellular traps as prognostic markers in COVID-19: a welcome piece to the puzzle. Arterioscler Thromb Vasc Biol 2021;41:995–8, https://doi.org/10.1161/atvbaha.120.315633.
Barnes, BJ, Adrover, JM, Baxter-Stoltzfus, A, Borczuk, A, Cools-Lartigue, J, Crawford, JM, et al.. Targeting potential drivers of COVID-19: neutrophil extracellular traps. J Exp Med 2020;217:e20200652. https://doi.org/10.1084/jem.20200652.
Ackermann, M, Anders, HJ, Bilyy, R, Bowlin, GL, Daniel, C, De Lorenzo, R, et al.. Patients with COVID-19: in the dark-NETs of neutrophils. Cell Death Differ 2021;28:3125–39, https://doi.org/10.1038/s41418-021-00805-z.
Fei, Y, Tang, N, Liu, H, Cao, W. Coagulation dysfunction. Arch Pathol Lab Med 2020;144:1223–9, https://doi.org/10.5858/arpa.2020-0324-sa.
Hernandez-Huerta, MT, Perez-Santiago, AD, Perez-Campos Mayoral, L, Sanchez Navarro, LM, Rodal Canales, FJ, Majluf-Cruz, A, et al.. Mechanisms of immunothrombosis by SARS-CoV-2. Biomolecules 2021;11:1550. https://doi.org/10.3390/biom11111550.
Zuo, Y, Zuo, M, Yalavarthi, S, Gockman, K, Madison, JA, Shi, H, et al.. Neutrophil extracellular traps and thrombosis in COVID-19. J Thromb Thrombolysis 2021;51:446–53, https://doi.org/10.1007/s11239-020-02324-z.
Veras, FP, Pontelli, MC, Silva, CM, Toller-Kawahisa, JE, de Lima, M, Nascimento, DC, et al.. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J Exp Med 2020;217:e20201129. https://doi.org/10.1084/jem.20201129.
Singh, A, Verma, S, Modak, SB, Chaturvedi, MM, Purohit, JS. Extra-nuclear histones: origin, significance and perspectives. Mol Cell Biochem 2022;477:507–24, https://doi.org/10.1007/s11010-021-04300-4.
Hu, B, Guo, H, Zhou, P, Shi, ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 2021;19:141–54, https://doi.org/10.1038/s41579-020-00459-7.
Mokhtari, T, Hassani, F, Ghaffari, N, Ebrahimi, B, Yarahmadi, A, Hassanzadeh, G. COVID-19 and multiorgan failure: a narrative review on potential mechanisms. J Mol Histol 2020;51:613–28, https://doi.org/10.1007/s10735-020-09915-3.
Ali, MAM, Spinler, SA. COVID-19 and thrombosis: from bench to bedside. Trends Cardiovasc Med 2021;31:143–60, https://doi.org/10.1016/j.tcm.2020.12.004.
Tsourouktsoglou, TD, Warnatsch, A, Ioannou, M, Hoving, D, Wang, Q, Papayannopoulos, V. Histones, DNA, and citrullination promote neutrophil extracellular trap inflammation by regulating the localization and activation of TLR4. Cell Rep 2020;31:107602, https://doi.org/10.1016/j.celrep.2020.107602.
Hong, W, Yang, J, Zou, J, Bi, Z, He, C, Lei, H, et al.. Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells. Cell Mol Immunol 2022;19:577–87. https://doi.org/10.1038/s41423-022-00845-6.
Middleton, EA, He, XY, Denorme, F, Campbell, RA, Ng, D, Salvatore, SP, et al.. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood 2020;136:1169–79, https://doi.org/10.1182/blood.2020007008.
Busch, MH, Timmermans, S, Nagy, M, Visser, M, Huckriede, J, Aendekerk, JP, et al.. Neutrophils and contact activation of coagulation as potential drivers of COVID-19. Circulation 2020;142:1787–90, https://doi.org/10.1161/circulationaha.120.050656.
Zuo, Y, Yalavarthi, S, Shi, H, Gockman, K, Zuo, M, Madison, JA, et al.. Neutrophil extracellular traps in COVID-19. JCI Insight 2020;5:e138999. https://doi.org/10.1172/jci.insight.138999.
Blasco, A, Coronado, MJ, Hernandez-Terciado, F, Martin, P, Royuela, A, Ramil, E, et al.. Assessment of neutrophil extracellular traps in coronary thrombus of a case series of patients with COVID-19 and myocardial infarction. JAMA Cardiol 2020;6:1–6. https://doi.org/10.1001/jamacardio.2020.7308.
Gueant, JL, Gueant-Rodriguez, RM, Fromonot, J, Oussalah, A, Louis, H, Chery, C, et al.. Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19. Allergy 2021;76:1846–58, https://doi.org/10.1111/all.14746.
Huckriede, J, de Vries, F, Hultstrom, M, Wichapong, K, Reutelingsperger, C, Lipcsey, M, et al.. Histone H3 cleavage in severe COVID-19 ICU patients. Front Cell Infect Microbiol 2021;11:694186, https://doi.org/10.3389/fcimb.2021.694186.
Huckriede, J, Anderberg, SB, Morales, A, de Vries, F, Hultstrom, M, Bergqvist, A, et al.. Evolution of NETosis markers and DAMPs have prognostic value in critically ill COVID-19 patients. Sci Rep 2021;11:15701, https://doi.org/10.1038/s41598-021-95209-x.
Shaw, RJ, Abrams, ST, Austin, J, Taylor, JM, Lane, S, Dutt, T, et al.. Circulating histones play a central role in COVID-19-associated coagulopathy and mortality. Haematologica 2021;106:2493–8, https://doi.org/10.3324/haematol.2021.278492.
Cavalier, E, Guiot, J, Lechner, K, Dutsch, A, Eccleston, M, Herzog, M, et al.. Circulating nucleosomes as potential markers to monitor COVID-19 disease progression. Front Mol Biosci 2021;8:600881, https://doi.org/10.3389/fmolb.2021.600881.
Ng, H, Havervall, S, Rosell, A, Aguilera, K, Parv, K, von Meijenfeldt, FA, et al.. Circulating markers of neutrophil extracellular traps are of prognostic value in patients with COVID-19. Arterioscler Thromb Vasc Biol 2021;41:988–94, https://doi.org/10.1161/atvbaha.120.315267.
Seery, V, Raiden, SC, Algieri, SC, Grisolia, NA, Filippo, D, De Carli, N, et al.. Blood neutrophils from children with COVID-19 exhibit both inflammatory and anti-inflammatory markers. EBioMedicine 2021;67:103357, https://doi.org/10.1016/j.ebiom.2021.103357.
Godement, M, Zhu, J, Cerf, C, Vieillard-Baron, A, Maillon, A, Zuber, B, et al.. Neutrophil extracellular traps in SARS-CoV2 related pneumonia in ICU patients: the NETCOV2 study. Front Med 2021;8:615984, https://doi.org/10.3389/fmed.2021.615984.
Bouchard, BA, Colovos, C, Lawson, MA, Osborn, ZT, Sackheim, AM, Mould, KJ, et al.. Increased histone-DNA complexes and endothelial-dependent thrombin generation in severe COVID-19. Vasc Pharmacol 2022;142:106950, https://doi.org/10.1016/j.vph.2021.106950.
Aymonnier, K, Ng, J, Fredenburgh, LE, Zambrano-Vera, K, Munzer, P, Gutch, S, et al.. Inflammasome activation in neutrophils of patients with severe COVID-19. Blood Adv 2022;6:2001–13. https://doi.org/10.1182/bloodadvances.2021005949.
Traby, L, Kollars, M, Kussmann, M, Karer, M, Sinkovec, H, Lobmeyr, E, et al.. Extracellular vesicles and citrullinated histone H3 in coronavirus disease 2019 patients. Thromb Haemostasis 2022;122:113–22, https://doi.org/10.1055/a-1522-4131.
Konig, MF, Andrade, F. A critical reappraisal of neutrophil extracellular traps and NETosis mimics based on differential requirements for protein citrullination. Front Immunol 2016;7:461, https://doi.org/10.3389/fimmu.2016.00461.
Liu, ML, Lyu, X, Werth, VP. Recent progress in the mechanistic understanding of NET formation in neutrophils. FEBS J 2021. https://doi.org/10.1111/febs.16036.
Keane, C, Coalter, M, Martin-Loeches, I. Immune system disequilibrium-neutrophils, their extracellular traps, and COVID-19-induced sepsis. Front Med 2021;8:711397, https://doi.org/10.3389/fmed.2021.711397.
Michels, A, Albanez, S, Mewburn, J, Nesbitt, K, Gould, TJ, Liaw, PC, et al.. Histones link inflammation and thrombosis through the induction of Weibel-Palade body exocytosis. J Thromb Haemostasis 2016;14:2274–86, https://doi.org/10.1111/jth.13493.
Bikdeli, B, Madhavan, MV, Gupta, A, Jimenez, D, Burton, JR, Der Nigoghossian, C, et al.. Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research. Thromb Haemostasis 2020;120:1004–24, https://doi.org/10.1055/s-0040-1713152.
Saffarzadeh, M, Juenemann, C, Queisser, MA, Lochnit, G, Barreto, G, Galuska, SP, et al.. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One 2012;7:e32366, https://doi.org/10.1371/journal.pone.0032366.
Wildhagen, KC, Wiewel, MA, Schultz, MJ, Horn, J, Schrijver, R, Reutelingsperger, CP, et al.. Extracellular histone H3 levels are inversely correlated with antithrombin levels and platelet counts and are associated with mortality in sepsis patients. Thromb Res 2015;136:542–7, https://doi.org/10.1016/j.thromres.2015.06.035.
Zhang, X, Li, X. The role of histones and heparin in sepsis: a review. J Intensive Care Med 2022;37:319–26, https://doi.org/10.1177/0885066621992320.
Shi, H, Gandhi, AA, Smith, SA, Wang, Q, Chiang, D, Yalavarthi, S, et al.. Endothelium-protective, histone-neutralizing properties of the polyanionic agent defibrotide. JCI Insight 2021;6:e149149. https://doi.org/10.1172/jci.insight.149149.
Ebeyer-Masotta, M, Eichhorn, T, Weiss, R, Semak, V, Laukova, L, Fischer, MB, et al.. Heparin-functionalized adsorbents eliminate central effectors of immunothrombosis, including platelet factor 4, high-mobility group box 1 protein and histones. Int J Mol Sci 2022;23:1823. https://doi.org/10.3390/ijms23031823.
Hogwood, J, Pitchford, S, Mulloy, B, Page, C, Gray, E. Heparin and non-anticoagulant heparin attenuate histone-induced inflammatory responses in whole blood. PLoS One 2020;15:e0233644, https://doi.org/10.1371/journal.pone.0233644.
Ammollo, CT, Semeraro, N, Carratu, MR, Colucci, M, Semeraro, F. Histones differentially modulate the anticoagulant and profibrinolytic activities of heparin, heparin derivatives, and dabigatran. J Pharmacol Exp Therapeut 2016;356:305–13, https://doi.org/10.1124/jpet.115.229823.
Wildhagen, KC, Garcia de Frutos, P, Reutelingsperger, CP, Schrijver, R, Areste, C, Ortega-Gomez, A, et al.. Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsis. Blood 2014;123:1098–101, https://doi.org/10.1182/blood-2013-07-514984.
Lippi, G, Henry, BM, Favaloro, EJ. The benefits of heparin use in COVID-19: pleiotropic antiviral activity beyond anticoagulant and anti-inflammatory properties. Semin Thromb Hemost 2022. https://doi.org/10.1055/s-0042-1742740 [Epub ahead of print].
Lippi, G, Sanchis-Gomar, F, Henry, BM. Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm. Ann Transl Med 2020;8:497, https://doi.org/10.21037/atm.2020.03.157.
Christensen, B, Favaloro, EJ, Lippi, G, Van Cott, EM. Hematology laboratory abnormalities in patients with coronavirus disease 2019 (COVID-19). Semin Thromb Hemost 2020;46:845–9, https://doi.org/10.1055/s-0040-1715458.
Gallo, CG, Fiorino, S, Posabella, G, Antonacci, D, Tropeano, A, Pausini, E, et al.. COVID-19, what could sepsis, severe acute pancreatitis, gender differences, and aging teach us? Cytokine 2021;148:155628, https://doi.org/10.1016/j.cyto.2021.155628.
Cani, E, Dwivedi, DJ, Liaw, KL, Fraser, DD, Yeh, CH, Martin, C, et al.. Immunothrombosis biomarkers for distinguishing coronavirus disease 2019 patients from noncoronavirus disease septic patients with pneumonia and for predicting ICU mortality. Critical Care Explor 2021;3:e0588, https://doi.org/10.1097/cce.0000000000000588.
Higgins, TL, Stark, MM, Henson, KN, Freeseman-Freeman, L. Coronavirus disease 2019 ICU patients have higher-than-expected acute physiology and chronic health evaluation-adjusted mortality and length of stay than viral pneumonia ICU patients. Crit Care Med 2021;49:e701–6, https://doi.org/10.1097/ccm.0000000000005012.
Higgins, V, Sohaei, D, Diamandis, EP, Prassas, I. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci 2021;58:297–310, https://doi.org/10.1080/10408363.2020.1860895.
Yong, SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis 2021;53:737–54, https://doi.org/10.1080/23744235.2021.1924397.
Desai, AD, Lavelle, M, Boursiquot, BC, Wan, EY. Long-term complications of COVID-19. Am J Physiol Cell Physiol 2022;322:C1–11, https://doi.org/10.1152/ajpcell.00375.2021.
Chen, CH, Lin, SW, Shen, CF, Hsieh, KS, Cheng, CM. Biomarkers during COVID-19: mechanisms of change and implications for patient outcomes. Diagnostics 2022;12:509. https://doi.org/10.3390/diagnostics12020509.
Chlamydas, S, Papavassiliou, AG, Piperi, C. Epigenetic mechanisms regulating COVID-19 infection. Epigenetics 2021;16:263–70, https://doi.org/10.1080/15592294.2020.1796896.
Sharma, N, Haggstrom, L, Sohrabipour, S, Dwivedi, DJ, Liaw, PC. Investigations of the effectiveness of heparin variants as inhibitors of histones. J Thromb Haemostasis 2022;20:1485–95. https://doi.org/10.1111/jth.15706.
Ahmadi, E, Bagherpour, Z, Zarei, E, Omidkhoda, A. Pathological effects of SARS-CoV-2 on hematological and immunological cells: alterations in count, morphology, and function. Pathol Res Pract 2022;231:153782, https://doi.org/10.1016/j.prp.2022.153782.
Zhou, Y, Fu, B, Zheng, X, Wang, D, Zhao, C, Qi, Y, et al.. Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. Natl Sci Rev 2020;7:998–1002, https://doi.org/10.1093/nsr/nwaa041.
Pence, BD. Aging and monocyte immunometabolism in COVID-19. Aging 2021;13:9154–5, https://doi.org/10.18632/aging.202918.
Pence, BD. Severe COVID-19 and aging: are monocytes the key? Geroscience 2020;42:1051–61, https://doi.org/10.1007/s11357-020-00213-0.
Pence, BD. Atypical monocytes in COVID-19: lighting the fire of cytokine storm? J Leukoc Biol 2021;109:7–8, https://doi.org/10.1002/jlb.5ce0920-613r.
Lipp, P, Ruhnau, J, Lange, A, Vogelgesang, A, Dressel, A, Heckmann, M. Less neutrophil extracellular trap formation in term newborns than in adults. Neonatology 2017;111:182–8, https://doi.org/10.1159/000452615.